These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12859941)

  • 21. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury.
    Widenfalk J; Lipson A; Jubran M; Hofstetter C; Ebendal T; Cao Y; Olson L
    Neuroscience; 2003; 120(4):951-60. PubMed ID: 12927201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
    Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT;
    Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
    Khan TA; Sellke FW; Laham RJ
    Expert Opin Pharmacother; 2003 Feb; 4(2):219-26. PubMed ID: 12562312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing pathological regression of blood vessels.
    Keshet E
    J Clin Invest; 2003 Jul; 112(1):27-9. PubMed ID: 12840056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tipping the balance for angiogenic disorders.
    Gao G; Ma J
    Drug Discov Today; 2002 Feb; 7(3):171-2. PubMed ID: 11815230
    [No Abstract]   [Full Text] [Related]  

  • 26. Dilemma of angiogenesis.
    SoRelle R
    Circulation; 2000 Jan; 101(2):E23-4. PubMed ID: 10637212
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular growth factors for coronary angiogenesis.
    Lee CH; Smits PC
    J Interv Cardiol; 2002 Dec; 15(6):511-8. PubMed ID: 12476656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
    Henry TD; Annex BH; McKendall GR; Azrin MA; Lopez JJ; Giordano FJ; Shah PK; Willerson JT; Benza RL; Berman DS; Gibson CM; Bajamonde A; Rundle AC; Fine J; McCluskey ER;
    Circulation; 2003 Mar; 107(10):1359-65. PubMed ID: 12642354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic angiogenesis for heart failure.
    Isner JM; Losordo DW
    Nat Med; 1999 May; 5(5):491-2. PubMed ID: 10229223
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetech enlightens other angiogenesis programs.
    Brower V
    Nat Biotechnol; 1999 Apr; 17(4):326-7. PubMed ID: 10207873
    [No Abstract]   [Full Text] [Related]  

  • 31. Gene therapy with vascular endothelial growth factor reduces angina.
    Merkle CJ; Montgomery DW
    J Cardiovasc Nurs; 2003; 18(1):38-43. PubMed ID: 12537088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic angiogenesis: time for the next phase.
    Pantely GA; Porter JM
    J Am Coll Cardiol; 2000 Oct; 36(4):1245-7. PubMed ID: 11028478
    [No Abstract]   [Full Text] [Related]  

  • 33. [VEGF in therapeutic coronary and peripheral artery angiogenesis].
    Elbaz M; Malavaud B
    Pathol Biol (Paris); 1999 Apr; 47(4):380-4. PubMed ID: 10372409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis (clinical trials).
    Laham R
    Can J Cardiol; 2001 May; 17 Suppl A():29A-32A. PubMed ID: 11381293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease].
    Stegmann TJ; Hoppert T; Schneider A; Gemeinhardt S; Köcher M; Ibing R; Strupp G
    Herz; 2000 Sep; 25(6):589-99. PubMed ID: 11076317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic angiogenesis in ischemic heart disease.
    Helisch A; Ware JA
    Thromb Haemost; 1999 Aug; 82(2):772-80. PubMed ID: 10605781
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic angiogenesis.
    Henry TD
    BMJ; 1999 Jun; 318(7197):1536-9. PubMed ID: 10356013
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
    Harrigan MR; Ennis SR; Sullivan SE; Keep RF
    Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds.
    Nikol S; Pelisek J; Engelmann MG; Shimizu M; Fuchs A; Golda A; Armeanu S; Mekkaoui C; Rolland PH
    J Endovasc Ther; 2002 Dec; 9(6):842-54. PubMed ID: 12546587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.